In Vivo Visualization and Characterization of Epithelial-Mesenchymal Transition in Breast Tumors

Cancer Research

Volumn 76, Issue 8, 2016, Pages 2094-2104

  Zhao, Zhen ^a,b   Zhu, Xiaoping ^b   Cui, Kemi ^b   Mancuso, James ^b   Federley, Richard ^b   Fischer, Kari ^b   Teng, Gao Jun ^a   Mittal, Vivek ^b   Gao, Dingcheng ^b   Zhao, Hong ^a,b   Wong, Stephen T C ^a,b,c  

^a SOUTHEAST UNIVERSITY   (China)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CABOZANTINIB; GREEN FLUORESCENT PROTEIN; RED FLUORESCENT PROTEIN; SCATTER FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CANCER SIZE; CELL MOTILITY; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MESENCHYME CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; SPINDLE CELL; TREATMENT RESPONSE; ANIMAL; DIAGNOSTIC IMAGING; DISEASE MODEL; EXPERIMENTAL MAMMARY NEOPLASM; FLUORESCENCE MICROSCOPY; PATHOLOGY; PROCEDURES; SCID MOUSE; TRANSGENIC MOUSE;

ANIMALS; DISEASE MODELS, ANIMAL; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, SCID; MICE, TRANSGENIC; MICROSCOPY, FLUORESCENCE;

EID: 84964560527     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-15-2662     Document Type: Article

References (36)

1. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009;119:1420-28.
2. Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell 2009;139:871-90.
3. Tsai JH, Yang J. Epithelial-mesenchymal plasticity in carcinoma metastasis. Genes Dev 2013;27:2192-206.
4. Nieto MA.Epithelial plasticity: a common theme in embryonic and cancer cells. Science 2013;342:1234850.
5. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002;2:442-54.
6. Fidler IJ. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 2003;3:453-8.
7. Santisteban M, Reiman JM, Asiedu NK, Behrens MD, Nassar A, Kalli KR, et al. Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells. Cancer Res 2009;69:2887-95.
8. Xie M, Zhang L, He CS, Xu F, Liu JL, Hu ZH, et al. Activation of notch-1 enhances epithelial-mesenchymal transition in gefitinib-acquired resistant lung cancer cells. J Cell Biochem 2012;113:1501-13.
9. Wessels JT, Busse AC, Mahrt J, Dullin C, Grabbe E, Mueller GA. In vivo imaging in experimental preclinical tumor research-a review. Cytometry A 2007;71:542-9.
10. Niesner RA, Hauser AE. Recent advances in dynamic intravital multiphoton microscopy. Cytometry A 2011;79:789-98.
11. Tanaka K, Toiyama Y, Inoue Y, Uchida K, Araki T, Mohri Y, et al. Intravital imaging of gastrointestinal diseases in preclinical models using two-photon laser scanning microscopy. Surg Today 2013;43:123-29.
12. Fischer KR, Durrans A, Lee S, Sheng J, Li F, Wong ST, et al. Epithelial-tomesenchymal transition is not required for lung metastasis but contributes to chemoresistance. Nature 2015;527:472-6.
13. Yin Z, Sadok A, Sailem H, McCarthy A, Xia XF, Li FH, et al. A screen for morphological complexity identifies regulators of switch-like transitions between discrete cell shapes. Nat Cell Biol 2013;15:860.
14. Xue CS, Plieth D, Venkov C, Xu C, Neilson EG. The gatekeeper effect of epithelial-mesenchymal transition regulates the frequency of breast cancer metastasis. Cancer Res 2003;63:3386-94.
15. Okada H, Danoff TM, Kalluri R, Neilson EG. Early role of Fsp1 in epithelial-mesenchymal transformation. Am J Physiol-Renal Physiol 1997;273:F563-F74.
16. Waldmeier L, Meyer-Schaller N, Diepenbruck M, Christofori G. Py2T murine breast cancer cells, a versatile model of TGFbeta-induced EMT in vitro and in vivo. PLoS ONE 2012;7:e48651.
17. Dumont N, Wilson MB, Crawford YG, Reynolds PA, Sigaroudinia M, Tlsty TD. Sustained induction of epithelial to mesenchymal transition activates DNA methylation of genes silenced in basal-like breast cancers. Proc Natl Acad Sci U S A 2008;105:14867-72.
18. Patsialou A, Bravo-Cordero JJ, Wang Y, Entenberg D, Liu H, Clarke M, et al. Intravital multiphoton imaging reveals multicellular streaming as a crucial component of in vivo cell migration in human breast tumors. Intravital 2013;2:e25294.
19. Cirri P, Chiarugi P. Cancer associated fibroblasts: the dark side of the coin. Am J Cancer Res 2011;1:482-97.
20. Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer 2006;6: 392-401.
21. Condeelis J, Segall JE. Intravital imaging of cell movement in tumours. Nat Rev Cancer 2003;3:921-30.
22. Vannucci L. Stroma as an active player in the development of the tumor microenvironment. Cancer Microenviron 2015;8:159-66.
23. You WK, Sennino B, Williamson CW, Falcon B, Hashizume H, Yao LC, et al. VEGF and c-Met blockade amplify angiogenesis inhibition in pancreatic Islet cancer. Cancer Res 2011;71:4758-68.
24. Yakes FM, Chen J, Tan J, Yamaguchi K, Shi Y, Yu P, et al. Cabozantinib (XL184), a novel MET and VEGFR2 inhibitor, simultaneously suppresses metastasis, angiogenesis, and tumor growth. Mol Cancer Ther 2011;10: 2298-308.
25. Castellone MD, Carlomagno F, Salvatore G, Santoro M. Receptor tyrosine kinase inhibitors in thyroid cancer. Best Pract Res Clin Endocrinol Metabol 2008;22:1023-38.
26. Mazzone M, Comoglio PM. The Met pathway: master switch and drug target in cancer progression. FASEB J 2006;20:1611-21.
27. Sennino B, Ishiguro-Oonuma T, Wei Y, Naylor RM, Williamson CW, Bhagwandin V, et al. Suppression of tumor invasion and metastasis by concurrent inhibition of c-Met and VEGF signaling in pancreatic neuroendocrine tumors. Cancer Discov 2012;2:270-87.
28. Oltean S, Sorg BS, Albrecht T, Bonano VI, Brazas RM, Dewhirst MW, et al. Alternative inclusion of fibroblast growth factor receptor 2 exon IIIc in Dunning prostate tumors reveals unexpected epithelial-mesenchymal plasticity. Proc Natl Acad Sci U S A 2006;103:14116-21.
29. Oltean S, Febbo PG, Garcia-Blanco MA. Dunning rat prostate adenocarcinomas and alternative splicing reporters: powerful tools to study epithelial plasticity in prostate tumors in vivo. Clin Exp Metastasis 2008;25:611-19.
30. Somarelli JA, Schaeffer D, Bosma R, Bonano VI, Sohn JW, Kemeny G, et al. Fluorescence-based alternative splicing reporters for the study of epithelial plasticity in vivo. Rna-a Publ Rna Soc 2013;19:116-27.
31. Choi Y, Kim HS, Woo J, Hwang EH, Cho KW, Kim S, et al. Real-time imaging of the epithelial-mesenchymal transition using microRNA-200a sequence-based molecular beacon-conjugated magnetic nanoparticles. PLoS ONE 2014;9:e102164.
32. Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2002;2:563-72.
33. Husemann Y, Geigl JB, Schubert F, Musiani P, Meyer M, Burghart E, et al. Systemic spread is an early step in breast cancer. Cancer Cell 2008; 13:58-68.
34. Engel J, Eckel R, Kerr J, Schmidt M, Furstenberger G, Richter R, et al. The process of metastasisation for breast cancer. Eur J Cancer 2003;39: 1794-806.
35. van't Veer LJ, Dai HY, van de Vijver MJ, He YDD, Hart AAM, Mao M, et al. Gene-expression profiling predicts clinical outcome of breast cancer. Nature 2002;415:530-36.
36. Taube JH, Herschkowitz JI, Komurov K, Zhou AY, Gupta S, Yang J, et al. Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proc Natl Acad Sci U S A 2010;107:15449-54.